Sustained growth factor delivery in tissue engineering applications
1UCLA, Los Angeles, CA, USA.
Annals of Biomedical Engineering
|December 10, 2013
Summary
Covalent immobilization of growth factors in scaffolds offers sustained delivery for tissue engineering, improving cell responses and regeneration while avoiding risks of systemic administration.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Systemic growth factor delivery lacks tissue specificity and sustained localization, leading to adverse effects like overgrowth and inflammation.
- Implanted scaffolds provide a promising platform for controlled cell behavior modulation.
- Current methods for sustained delivery often rely on covalent immobilization techniques.
Purpose of the Study:
- To review covalent immobilization strategies for sustained growth factor delivery in tissue engineering.
- To analyze techniques based on design, bioactivity, stability, efficiency, and spatiotemporal distribution.
- To cover the biological responses to sustained growth factor delivery for tissue regeneration.
Main Methods:
- Review of literature on covalent immobilization techniques for growth factor delivery.
- Analysis of protein attachment methods, including tethering to scaffold materials.
- Examination of studies detailing cell-scaffold interactions and tissue regeneration outcomes.
Main Results:
- Covalent immobilization enables sustained and localized growth factor release, crucial for tissue engineering.
- Techniques vary in their impact on protein bioactivity, stability, and release kinetics.
- Sustained delivery promotes enhanced cell proliferation, differentiation, and extracellular matrix production.
Conclusions:
- Covalent immobilization is a key strategy for achieving controlled growth factor delivery in tissue engineering.
- Optimizing immobilization techniques is essential for maximizing therapeutic efficacy and minimizing side effects.
- This review provides guidance for selecting appropriate strategies for regenerative medicine applications.


